株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の乳癌スクリーニング市場の予測:マンモグラフィー、MRI、超音波

Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis

発行 Renub Research 商品コード 312128
出版日 ページ情報 英文 380 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.09円で換算しております。
世界の乳癌スクリーニング市場の予測:マンモグラフィー、MRI、超音波 Breast Cancer Screening Market, Global Forecast by Screening Test, Population, Countries, Company Analysis
出版日: 2020年05月01日 ページ情報: 英文 380 Pages
概要

乳癌スクリーニング市場は、2024年末までに、210億米ドルに達すると予測されています。

当レポートでは、世界の乳癌スクリーニング市場について調査分析し、成長促進要因と課題、市場の分析、スクリーニング人口と予測について、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 世界のスクリーニング人口

  • 世界のスクリーニング人口
  • MRI・超音波スクリーニング人口

第3章 世界の乳癌スクリーニング市場

  • マンモグラフィースクリーニング市場
  • MRIスクリーニング市場
  • 超音波スクリーニング市場

第4章 人口 - 世界の乳癌スクリーニング

  • 世界の乳癌スクリーニング人口シェア
  • マンモグラフィースクリーニング人口シェア
  • MRI・超音波スクリーニング人口シェア

第5章 市場シェア - 世界の乳癌スクリーニング

  • 乳癌スクリーニング市場シェア
  • マンモグラフィースクリーニング市場シェア
  • MRIスクリーニング市場シェア
  • 超音波スクリーニング市場シェア

第6章 英国 - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第7章 フランス - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第8章 ドイツ - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第9章 イタリア - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第10章 スペイン - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第11章 スイス - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第12章 ノルウェー - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第13章 オランダ - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第14章 米国 - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第15章 カナダ - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第16章 日本 - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第17章 韓国 - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第18章 シンガポール - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第19章 マレーシア - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第20章 インド - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第21章 中国 - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第22章 タイ - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第23章 ブラジル - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第24章 オーストラリア - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第25章 ニュージーランド - 乳癌スクリーニング人口と市場

  • 乳癌スクリーニング人口と予測
  • 乳癌スクリーニング市場と予測

第26章 乳癌スクリーニング市場の成長促進要因

  • 女性の乳癌治療・意識の向上に対する世界的イニシアチブの増加
  • 世界の乳癌件数の増加
  • FDAによるマンモグラフィー装置の再分類

第27章 乳癌スクリーニング市場の課題

  • 乳癌マンモグラフィースクリーニングに対する意見の相違
  • 乳癌スクリーニングに対する社会的・文化的障壁
図表

List of Figures

  • Figure-01: Global - Breast Cancer Screening Population (Million), 2012 - 2019
  • Figure-02: Global - Forecast for Breast Cancer Screening Population (Million), 2020 - 2026
  • Figure-03: Global - Breast Cancer Mammography Screening Population (Million), 2012 - 2019
  • Figure-04: Global - Forecast for Breast Cancer Mammography Screening Population (Million), 2020 - 2026
  • Figure-05: Global - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-06: Global - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-07: Global - Breast Cancer Screening Market (Billion US$), 2012 - 2019
  • Figure-08: Global - Forecast for Breast Cancer Screening Market (Billion US$), 2020 - 2026
  • Figure-09: Global - Breast Cancer Mammography Screening Market (Billion US$), 2012 - 2019
  • Figure-10: Global - Forecast for Breast Cancer Mammography Screening Market (Billion US$), 2020 - 2026
  • Figure-11: Global - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-12: Global - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-13: Worldwide - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-14: Worldwide - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020- 2026
  • Figure-15: United Kingdom - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-16: United Kingdom - Forecast for Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-17: United Kingdom - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-18: United Kingdom - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-19: United Kingdom - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-20: United Kingdom - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-21: United Kingdom - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-22: United Kingdom - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-23: United Kingdom - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-24: United Kingdom - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-25: United Kingdom - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-26: United Kingdom - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-27: United Kingdom - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-28: United Kingdom - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-29: France - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-30: France - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-31: France - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-32: France - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-33: France - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-34: France - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-35: France - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-36: France - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-37: France - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-38: France - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-39: France - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-40: France - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-41: France - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-42: France - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-43: Germany - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-44: Germany - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-45: Germany - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-46: Germany - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-47: Germany - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-48: Germany - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-49: Germany - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-50: Germany - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-51: Germany - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-52: Germany - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-53: Germany - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-54: Germany - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-55: Germany - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-56: Germany - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-57: Italy - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-58: Italy - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-59: Italy - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-60: Italy - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-61: Italy - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-62: Italy - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-63: Italy - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-64: Italy - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-65: Italy - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-66: Italy - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-67: Italy - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-68: Italy - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-69: Italy - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-70: Italy - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-71: Spain - Breast Cancer Screening Population (Thousand), 2012 - 2018
  • Figure-72: Spain - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-73: Spain - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-74: Spain - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-75: Spain - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 201
  • Figure-76: Spain - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-77: Spain - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-78: Spain - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-79: Spain - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-80: Spain - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-81: Spain - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-82: Spain - Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2020 - 2026
  • Figure-83: Spain - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-84: Spain - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2020 - 2026
  • Figure-85: Switzerland - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-86: Switzerland - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-87: Switzerland - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-88: Switzerland - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-89: Switzerland - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-90: Switzerland - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-91: Switzerland - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-92: Switzerland - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-93: Switzerland - Breast Cancer Mammography Screening Market (Million US$), 2011 - 2017
  • Figure-94: Switzerland - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-95: Switzerland - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-96: Switzerland - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-97: Switzerland - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-98: Switzerland - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-99: Norway - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-100: Norway - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-101: Norway - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-102: Norway - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-103: Norway - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-104: Norway - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-105: Norway - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-106: Norway - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-107: Norway - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-108: Norway - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-109: Norway - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-110: Norway - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-111: Norway - Breast Cancer Ultrasound Screening Market (Thousand US$), 2012 - 2019
  • Figure-112: Norway - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2020 - 2026
  • Figure-113: Netherlands - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-114: Netherlands - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-115: Netherlands - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-116: Netherlands - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-117: Netherlands - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-118: Netherlands - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-119: Netherlands - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-120: Netherlands - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-121: Netherlands - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-122: Netherlands - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-123: Netherlands - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-124: Netherlands - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-125: Netherlands - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-126: Netherlands - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-127: United States - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-128: United States - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-129: United States - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-120: United States - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-131: United States - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-132: United States - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-133: United States - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-134: United States - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-135: United States - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-136: United States - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-137: United States - Breast Cancer MRI Screening Market (Million US$), 2011 - 2017
  • Figure-138: United States - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-139: United States - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-140: United States - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-141: Canada - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-142: Canada - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-143: Canada - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-144: Canada - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-145: Canada - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-146: Canada - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-147: Canada - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-148: Canada - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-149: Canada - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-150: Canada - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-151: Canada - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-152: Canada - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-153: Canada - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-154: Canada - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-155: Japan - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-156: Japan - Forecast for Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-157: Japan - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-158: Japan - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-159: Japan - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2011 - 2017
  • Figure-160: Japan - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-161: Japan - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-162: Japan - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-163: Japan - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-164: Japan - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-165: Japan - Breast Cancer MRI Screening Market (Milion US$), 2012 - 2019
  • Figure-166: Japan - Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2020 - 2026
  • Figure-167: Japan - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-168: Japan - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2020 - 2026
  • Figure-169: Korea - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-170: Korea - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-171: Korea - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-172: Korea - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-173: Korea - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-174: Korea - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-175: Korea - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-176: Korea - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-177: Korea - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-178: Korea - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-179: Korea - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-180: Korea - Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2020 - 2026
  • Figure-181: Korea - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-182: Korea - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-183: Singapore - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-184: Singapore - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-185: Singapore - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-186: Singapore - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-187: Singapore - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-188: Singapore - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-189: Singapore - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-190: Singapore - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-191: Singapore - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-192: Singapore - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-193: Singapore - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-194: Singapore - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-195: Singapore - Breast Cancer Ultrasound Screening Market (Thousand US$), 2012 - 2019
  • Figure-196: Singapore - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2020 - 2026
  • Figure-197: Malaysia - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-198: Malaysia - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-199: Malaysia - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-200: Malaysia - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-201: Malaysia - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-202: Malaysia - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-203: Malaysia - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-204: Malaysia - Forecast for Breast Cancer Screening Market (Million US$), 2018 - 2024
  • Figure-205: Malaysia - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-206: Malaysia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-207: Malaysia - Breast Cancer MRI Screening Market (Thousand US$), 2012 - 2019
  • Figure-208: Malaysia - Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2020 - 2026
  • Figure-209: Malaysia - Breast Cancer Ultrasound Screening Market (Thousand US$), 2012 - 2019
  • Figure-210: Malaysia - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2018 - 2024
  • Figure-211: India - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-212: India - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-213: India - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-214: India - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-215: India - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-216: India - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-217: India - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-218: India - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-219: India - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-220: India - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-221: India - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-222: India - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-223: India - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-224: India - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-225: China - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-226: China - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-227: China - Breast Cancer Mammography Screening Population (Thousand), 2011 - 2017
  • Figure-228: China - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-229: China - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-230: China - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-231: China - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-232: China - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-233: China - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-234: China - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-235: China - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-236: China - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-237: China - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-238: China - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-239: Thailand - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-240: Thailand - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-241: Thailand - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-242: Thailand - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-243: Thailand - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-244: Thailand - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-245: Thailand - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-246: Thailand - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-247: Thailand - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-248: Thailand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-249: Thailand - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-250: Thailand - Forecast for Breast Cancer MRI Screening Market (Thousand US$), 2020 - 2026
  • Figure-251: Thailand - Breast Cancer Ultrasound Screening Market (Thousand US$), 2012 - 2019
  • Figure-252: Thailand - Forecast for Breast Cancer Ultrasound Screening Market (Thousand US$), 2020 - 2026
  • Figure-253: Brazil - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-254: Brazil - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-255: Brazil - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-256: Brazil - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-257: Brazil - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-258: Brazil - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-259: Brazil - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-260: Brazil - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-261: Brazil - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-262: Brazil - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-263: Brazil - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-264: Brazil - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-265: Brazil - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-266: Brazil - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-267: Australia - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-268: Australia - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-269: Australia - Breast Cancer Mammography Screening Population (Thousand), 2012 - 2019
  • Figure-270: Australia - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-271: Australia - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-272: Australia - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-273: Australia - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-274: Australia - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-275: Australia - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2019
  • Figure-276: Australia - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-277: Australia - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-276: Australia - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-278: Australia - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-279: Australia - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
  • Figure-280: New Zealand - Breast Cancer Screening Population (Thousand), 2012 - 2019
  • Figure-281: New Zealand - Forecast For Breast Cancer Screening Population (Thousand), 2020 - 2026
  • Figure-282: New Zealand - Breast Cancer Mammography Screening Population (Thousand), 2011 - 2017
  • Figure-283: New Zealand - Forecast for Breast Cancer Mammography Screening Population (Thousand), 2020 - 2026
  • Figure-284: New Zealand - Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2012 - 2019
  • Figure-285: New Zealand - Forecast for Breast Cancer MRI & Ultrasound Screening Population (Thousand), 2020 - 2026
  • Figure-286: New Zealand - Breast Cancer Screening Market (Million US$), 2012 - 2019
  • Figure-287: New Zealand - Forecast for Breast Cancer Screening Market (Million US$), 2020 - 2026
  • Figure-288: New Zealand - Breast Cancer Mammography Screening Market (Million US$), 2012 - 2016
  • Figure-289: New Zealand - Forecast for Breast Cancer Mammography Screening Market (Million US$), 2020 - 2026
  • Figure-290: New Zealand - Breast Cancer MRI Screening Market (Million US$), 2012 - 2019
  • Figure-291: New Zealand - Forecast for Breast Cancer MRI Screening Market (Million US$), 2020 - 2026
  • Figure-292: New Zealand - Breast Cancer Ultrasound Screening Market (Million US$), 2012 - 2019
  • Figure-293: New Zealand - Forecast for Breast Cancer Ultrasound Screening Market (Million US$), 2020 - 2026
目次

Globally, breast cancer is considered one of the most common cancers in women around the world. Breast cancer is also a leading cause of death from cancer in the world's least developed nations. Every year 1.7 Million new cases are diagnosed with breast cancer, and approximately 60% of deaths due to breast cancer occur around the world. Breast cancer is a form of cancer that occurs in the tissue of the breast. Formations of a lump in a breast and red patches on the skin are some of the typical breast cancer signs. Obesity, lack of physical activity, overexposure to radiation, and consuming alcohol are among the risk factors for breast cancer growth. According to Renub Research report, the Global Breast Cancer Screening Market is anticipated to reach US$ 51.8 Billion by the end of the year 2026, with double-digit CAGR during the forecast period.

COVID - 19 impact on Breast Cancer Screening Market Worldwide

The COVID-19 outbreak could have an impact on all drug companies manufacturing, supply chain, and clinical trial operations. In the year 2020, the global breast cancer screening population, as well as the market, will decline. The primary reason for this decline is a coronavirus. For a complete analysis, read our report as to how COVID - 19 is affecting every quarter of the year 2020 and when the market will revive? Other challenges of breast cancer screening are high medication costs, therapy-related adverse effects, and lengthy product approval times are responsible for curbing market growth.

Growth Factors for Global Breast Cancer Screening Market

The key growth factors of the breast cancer market are the increasing number of females suffering from breast cancer, growing older women population is the primary factor for the growth of the market. In addition to this adoption of an unhealthy lifestyle, the rise of the female geriatric population, exposure to harmful radiation, and increased policy measures have contributed to market growth.

Also, the incidence of breast cancer is rising in the lower-income countries due to an increase in life expectancy, adaption to increasing urbanization and western lifestyles. World over, more than half of the breast cancer cases now have been reported from low and middle-income countries (LMICs) as these countries do not have proper breast screening programs; hence, the majority of cases are diagnosed in late stages. Growing breast cancer incidences & mortality in the low and middle-income countries, these countries need to develop an effective breast cancer screening program strategy that will address the earlier deduction of incidence of breast cancer for women.

Some of the major breast cancer screening technologies which help to find breast cancer after diagnosis are as follows. Breast cancer screening technologies are MRI, Ultrasound, and mammography screening. Mammography screening aims at minimizing the death rate from breast cancer by identifying unsuspected breast cancers early. The breast cancer mammography screening market is flourishing, driven by advances in technologies and delivery models, product innovations, increasing use of digital mammography equipment, and growing public awareness. Globally, awareness about breast cancer is increasing, with more women coming forward for their yearly mammograms after the age of 40 years.

Besides, around the world, governments have introduced screening programs for early detection that entails a routine check-up. Several countries are already offering breast cancer screening programs for women, and the number is establishing these programs are steadily increasing. In Germany, for example, the "Mammo Screening" program exists since 2002. In the United States, most states are introducing laws requiring health insurance companies to reimburse all or part of the cost of screening mammograms. Furthermore, the NHS Breast Screening Program in the United Kingdom provides free breast screening every three years for all women aged. Also, continuous efforts are taken by various government agencies and NGOs, the worldwide market for breast cancer screening.

Renub Research latest study report "Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] Countries (United States, Canada, France, United Kingdom, Germany, Italy, Spain, Netherlands, Norway, Switzerland, China, India, Korea, Japan, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand, South Africa, United Arab Emirates, Saudi Arabia), Company Analysis (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG)" provides a detailed and comprehensive insight of the Breast Cancer Screening Market.

Screening Tests - Mammography is the Most Common Test for Breast Cancer Screening

Mammography is sophisticated medical imaging that uses a low-dose x-ray device to view human breasts indoors. Mammography plays a vital role in the early detection and treatment of women with breast diseases. Breast Magnetic Resonance Imaging (MRI) or breast ultrasound, in addition to mammography, also helps detect breast cancer in women.

Countries - Total 23 Countries Market & Population for Breast Cancer Screening, Mammography Screening, MRI Screening & Ultrasound Screening has been studied in the report

The study includes a comprehensive Breast cancer overview of Canada, France, Italy, Spain, Switzerland, Netherlands, Norway, India, Australia, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, New Zealand, South Africa, United Arab Emirates and Saudi Arabia Breast Cancer, Mammography, Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population and Market.

The report provides a complete analysis of the key Growth Drivers, Challenges, Market, Screened Population, and their projections for the upcoming years till 2026.

All the companies have been studied from two points:

  • Recent Developments
  • Sales Analysis

Company Analysis:

  • AstraZeneca
  • Novartis
  • Sanofi
  • Pfizer
  • Bayer AG

Breast Cancer Screening Market & Population - By Screening Tests Covered in the Report:

  • Mammography
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound

23 Regions Covered in the Report:

  • 1. United States
  • 2. Canada
  • 3. United Kingdom
  • 4. France
  • 5. Germany
  • 6. Italy
  • 7. Spain
  • 8. Netherlands
  • 9. Norway
  • 10. Switzerland
  • 11. India
  • 12. China
  • 13. Japan
  • 14. Korea
  • 15. Singapore
  • 16. Thailand
  • 17. Malaysia
  • 18. Brazil
  • 19. Australia
  • 20. New Zealand
  • 21. South Africa
  • 22. United Arab Emirates
  • 23. Saudi Arabia

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Global Breast Cancer Screening Population

  • 4.1 Mammography Screening Population
  • 4.2 MRI & Ultrasound Screening Population

5. Global Breast Cancer Screening Market

  • 5.1 Mammography Screening Market
  • 5.2 Magnetic Resonance Imaging (MRI) Screening Market
  • 5.3 Ultrasound Screening Market

6. Population Share - Global Breast Cancer Screening

  • 6.1 Breast Cancer Screening
  • 6.2 Mammography Screening
  • 6.3 MRI & Ultrasound Screening

7. Market Share - Global Breast Cancer Screening

  • 7.1 Breast Cancer Screening
  • 7.2 Mammography Screening
  • 7.3 MRI Screening
  • 7.4 Ultrasound Screening

8. United Kingdom - Breast Cancer Screening Population & Market

  • 8.1 United Kingdom Breast Cancer Screening Population & Forecast
    • 8.1.1 Mammography Screening Population
    • 8.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 8.2 United Kingdom Breast Cancer Screening Market & Forecast
    • 8.2.1 Mammography Screening Market
    • 8.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 8.2.3 Ultrasound Screening Market

9. France - Breast Cancer Screening Population & Market

  • 9.1 France Breast Cancer Screening Population & Forecast
    • 9.1.1 Mammography Screening Population
    • 9.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 9.2 France Breast Cancer Screening Market & Forecast
    • 9.2.1 Breast Cancer Mammography Screening Market
    • 9.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 9.2.3 Ultrasound Screening Market

10. Germany - Breast Cancer Screening Population & Market

  • 10.1 Germany Breast Cancer Screening Population & Forecast
    • 10.1.1 Mammography Screening Population
    • 10.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 10.2 Germany Breast Cancer Screening Market & Forecast
    • 10.2.1 Breast Cancer Mammography Screening Market
    • 10.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 10.2.3 Ultrasound Screening Market

11. Italy - Breast Cancer Screening Population & Market

  • 11.1 Italy Breast Cancer Screening Population & Forecast
    • 11.1.1 Mammography Screening Population
    • 11.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 11.2 Italy Breast Cancer Screening Market & Forecast
    • 11.2.1 Mammography Screening Market
    • 11.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 11.2.3 Ultrasound Screening Market

12. Spain - Breast Cancer Screening Population & Market

  • 12.1 Spain Breast Cancer Screening Population & Forecast
    • 12.1.1 Mammography Screening Population
    • 12.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 12.2 Spain Breast Cancer Screening Market & Forecast
    • 12.2.1 Mammography Screening Market
    • 12.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 12.2.3 Ultrasound Screening Market

13. Switzerland - Breast Cancer Screening Population & Market

  • 13.1 Switzerland Breast Cancer Screening Population & Forecast
    • 13.1.1 Mammography Screening Population
    • 13.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 13.2 Switzerland Breast Cancer Screening Market & Forecast
    • 13.2.1 Mammography Screening Market
    • 13.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 13.2.3 Ultrasound Screening Market

14. Norway - Breast Cancer Screening Population & Market

  • 14.1 Norway Breast Cancer Screening Population & Forecast
    • 14.1.1 Mammography Screening Population
    • 14.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 14.2 Norway Breast Cancer Screening Market & Forecast
    • 14.2.1 Mammography Screening Market
    • 14.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 14.2.3 Ultrasound Screening Market

15. Netherlands - Breast Cancer Screening Population & Market

  • 15.1 Netherlands Breast Cancer Screening Population & Forecast
    • 15.1.1 Mammography Screening Population
    • 15.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 15.2 Netherlands Breast Cancer Screening Market & Forecast
    • 15.2.1 Mammography Screening Market
    • 15.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 15.2.3 Ultrasound Screening Market

16. United States - Breast Cancer Screening Population & Market

  • 16.1 United States Breast Cancer Screening Population & Forecast
    • 16.1.1 Mammography Screening Population
    • 16.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 16.2 United States Breast Cancer Screening Market & Forecast
    • 16.2.1 Mammography Screening Market
    • 16.2.2 Breast Cancer Magnetic Resonance Imaging (MRI) Screening Market
    • 16.2.3 Ultrasound Screening Market

17. Canada - Breast Cancer Screening Population & Market

  • 17.1 Canada Breast Cancer Screening Population & Forecast
    • 17.1.1 Mammography Screening Population
    • 17.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 17.2 Canada Breast Cancer Screening Market & Forecast
    • 17.2.1 Mammography Screening Market
    • 17.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 17.2.3 Ultrasound Screening Market

18. Japan - Breast Cancer Screening Population & Market

  • 18.1 Japan Breast Cancer Screening Population & Forecast
    • 18.1.1 Mammography Screening Population
    • 18.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 18.2 Japan Breast Cancer Screening Market & Forecast
    • 18.2.1 Mammography Screening Market
    • 18.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 18.2.3 Ultrasound Screening Market

19. Korea - Breast Cancer Screening Population & Market

  • 19.1 Korea Breast Cancer Screening Population & Forecast
    • 19.1.1 Mammography Screening Population
    • 19.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 19.2 Korea Breast Cancer Screening Market & Forecast
    • 19.2.1 Mammography Screening Market
    • 19.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 19.2.3 Ultrasound Screening Market

20. Singapore - Breast Cancer Screening Population & Market

  • 20.1 Singapore Breast Cancer Screening Population & Forecast
    • 20.1.1 Mammography Screening Population
    • 20.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 20.2 Singapore Breast Cancer Screening Market & Forecast
    • 20.2.1 Mammography Screening Market
    • 20.2.2 Resonance Imaging (MRI) Screening Market
    • 20.2.3 Ultrasound Screening Market

21. Malaysia - Breast Cancer Screening Population & Market

  • 21.1 Malaysia Breast Cancer Screening Population & Forecast
    • 21.1.1 Mammography Screening Population
    • 21.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 21.2 Malaysia Breast Cancer Screening Market & Forecast
    • 21.2.1 Mammography Screening Market
    • 21.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 21.2.3 Ultrasound Screening Market

22. India - Breast Cancer Screening Population & Market

  • 22.1 India Breast Cancer Screening Population & Forecast
    • 22.1.1 Mammography Screening Population
    • 22.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 22.2 India Breast Cancer Screening Market & Forecast
    • 22.2.1 Mammography Screening Market
    • 22.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 22.2.3 Ultrasound Screening Market

23. China - Breast Cancer Screening Population & Market

  • 23.1 China Breast Cancer Screening Population & Forecast
    • 23.1.1 Mammography Screening Population
    • 23.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 23.2 China Breast Cancer Screening Market & Forecast
    • 23.2.1 Mammography Screening Market
    • 23.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 23.2.3 Ultrasound Screening Market

24. Thailand - Breast Cancer Screening Population & Market

  • 24.1 Thailand Breast Cancer Screening Population & Forecast
    • 24.1.1 Mammography Screening Population
    • 24.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 24.2 Thailand Breast Cancer Screening Market & Forecast
    • 24.2.1 Mammography Screening Market
    • 24.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 24.2.3 Ultrasound Screening Market

25. Brazil - Breast Cancer Screening Population & Market

  • 25.1 Brazil Breast Cancer Screening Population & Forecast
    • 25.1.1 Mammography Screening Population
    • 25.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 25.2 Brazil Breast Cancer Screening Market & Forecast
    • 25.2.1 Mammography Screening Market
    • 25.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 25.2.3 Ultrasound Screening Market

26. Australia - Breast Cancer Screening Population & Market

  • 26.1 Australia Breast Cancer Screening Population & Forecast
    • 26.1.1 Mammography Screening Population
    • 26.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 26.2 Australia Breast Cancer Screening Market & Forecast
    • 26.2.1 Mammography Screening Market
    • 26.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 26.2.3 Ultrasound Screening Market

27. New Zealand - Breast Cancer Screening Population & Market

  • 27.1 New Zealand Breast Cancer Screening Population & Forecast
    • 27.1.1 Mammography Screening Population
    • 27.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 27.2 New Zealand Breast Cancer Screening Market & Forecast
    • 27.2.1 Mammography Screening Market
    • 27.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 27.2.3 Ultrasound Screening Market

28. South Africa - Breast Cancer Screening Population & Market

  • 28.1 South Africa Breast Cancer Screening Population & Forecast
    • 28.1.1 Mammography Screening Population
    • 28.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 28.2 South Africa Breast Cancer Screening Market & Forecast
    • 28.2.1 Mammography Screening Market
    • 28.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 28.2.3 Ultrasound Screening Market

29. United Arab Emirates - Breast Cancer Screening Population & Market

  • 29.1 United Arab Emirates Breast Cancer Screening Population & Forecast
    • 29.1.1 Mammography Screening Population
    • 29.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 29.2 United Arab Emirates Breast Cancer Screening Market & Forecast
    • 29.2.1 Mammography Screening Market
    • 29.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 29.2.3 Ultrasound Screening Market

30. Saudi Arabia - Breast Cancer Screening Population & Market

  • 30.1 Saudi Arabia Breast Cancer Screening Population & Forecast
    • 30.1.1 Mammography Screening Population
    • 30.1.2 Magnetic Resonance Imaging (MRI) and Ultrasound Screening Population
  • 30.2 Saudi Arabia Breast Cancer Screening Market & Forecast
    • 30.2.1 Mammography Screening Market
    • 30.2.2 Magnetic Resonance Imaging (MRI) Screening Market
    • 30.2.3 Ultrasound Screening Market

31. Growth Drivers

  • 31.1 Increasing Women's Breast Cancer Care
  • 31.2 Growing Breast Cancer Cases
  • 31.3 Reclassification of Mammography Equipment by FDA

32. Breast Cancer Screening Market Challenges

  • 32.1 Difference of Opinion on Breast Cancer Mammography Screening
  • 32.2 Societal and Cultural Barriers for Breast Cancer Screening

33. Company Analysis

  • 33.1 AstraZeneca
    • 33.1.1 Resent Development
    • 33.1.2 Revenue
  • 33.2 Novartis
    • 33.2.1 Resent Development
    • 33.2.2 Revenue
  • 33.3 Sanofi
    • 33.3.1 Resent Development
    • 33.3.2 Revenue
  • 33.4 Pfizer
    • 33.4.1 Resent Development
    • 33.4.2 Revenue
  • 33.5 Bayer AG
    • 33.5.1 Resent Development
    • 33.5.2 Revenue